English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Cancer stem cells can be therapeutic target.
Share :
EBCC 6 2008
15 - 19 Apr 2008
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
3 Dec 2008
Views:
15853
Rating:
Save
Rate video
Dr. Angel Rodriguez
New drug shrinks breast cancer tumours significantly in just six weeks research shows that cancer stem cells can be therapeutic target.
Categories:
Breast
Drug development
Related Videos
Abemaciclib and fulvestrant show improved efficacy in HR+, HER2- advanced...
Dr Kevin Kalinsky - Winship Cancer Institute, Georgia, USA
26 Jun 2024
Addition of atezolizumab to chemotherapy after surgery does not improve...
Dr Heather McArthur - UT Southwestern Medical Center, Dallas, USA
26 Apr 2024
EBCC 2024: Addressing inequalities across Europe in access to innovation for...
Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) and Dr...
25 Apr 2024
Comment: EBCC 2024 highlights
Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) andDr...
25 Apr 2024
Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours
Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Housten, USA
24 Apr 2024
Pembrolizumab improves breast cancer outcomes regardless of age or menopausal...
Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain
26 Mar 2024
Using AI to identify patients at increased risk of side effects from radiation...
Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK
25 Mar 2024
Adding atezolizumab to adjuvant chemotherapy for stage II and III triple...
Dr Michail Ignatiadis - Institut Jules Bordet, Brussels, Belgium
15 Jan 2024
CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer
Dr Sitna Mwanzi - Kenyatta National Hospital, Nairobi, Kenya
10 Jan 2024
More from
e
cancer